Dose Response Study of Lasofoxifene in Postmenopausal Women With Osteoporosis - Japanese Asian Dose Evaluation
Clinical trial NCT00143273 · COMPLETED
Trial details
- NCT number
- NCT00143273
- Sponsor
- Ligand Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2006-03-01
- Enrollment
- 497
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.